These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 7771801)

  • 1. Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity.
    Dudeja PK; Anderson KM; Harris JS; Buckingham L; Coon JS
    Arch Biochem Biophys; 1995 May; 319(1):309-15. PubMed ID: 7771801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
    Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
    FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in membrane lipid dynamics of leukemic cells undergoing growth arrest and differentiation: dependency on the inducing agent.
    Nathan I; Ben-Valid I; Henzel R; Masalha H; Baram SN; Dvilansky A; Parola AH
    Exp Cell Res; 1998 Mar; 239(2):442-6. PubMed ID: 9521862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma membrane fluidity measurements in intact endothelial cells: effect of hyperoxia on fluorescence anisotropies of 1-[4-(trimethylamino)phenyl]-6-phenyl hexa-1,3,5-triene.
    Sheridan NP; Block ER
    J Cell Physiol; 1988 Jan; 134(1):117-23. PubMed ID: 3335580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance.
    Coon JS; Knudson W; Clodfelter K; Lu B; Weinstein RS
    Cancer Res; 1991 Feb; 51(3):897-902. PubMed ID: 1988130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential.
    Alemán C; Annereau JP; Liang XJ; Cardarelli CO; Taylor B; Yin JJ; Aszalos A; Gottesman MM
    Cancer Res; 2003 Jun; 63(12):3084-91. PubMed ID: 12810633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistance.
    Ji X; Gao Y; Chen L; Zhang Z; Deng Y; Li Y
    Int J Pharm; 2012 Jan; 422(1-2):390-7. PubMed ID: 22001531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein does not reduce substrate concentration from the extracellular leaflet of the plasma membrane in living cells.
    Chen Y; Pant AC; Simon SM
    Cancer Res; 2001 Nov; 61(21):7763-9. PubMed ID: 11691790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane lipid dynamics in human promyelocytic leukemia cells sensitive and resistant to 12-O-tetradecanoylphorbol-13-acetate induction of differentiation.
    Fisher PB; Schachter D; Abbott RE; Callaham MF; Huberman E
    Cancer Res; 1984 Dec; 44(12 Pt 1):5550-4. PubMed ID: 6594192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of solutol HS 15, Cremophor EL and novel ethoxylated fatty acid surfactants as multidrug resistance modification agents.
    Buckingham LE; Balasubramanian M; Emanuele RM; Clodfelter KE; Coon JS
    Int J Cancer; 1995 Aug; 62(4):436-42. PubMed ID: 7635569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of membrane lipids and membrane fluidity in thermosensitivity and thermotolerance of mammalian cells.
    Konings AW; Ruifrok AC
    Radiat Res; 1985 Apr; 102(1):86-98. PubMed ID: 3983372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane fluidity changes in P. berghei-infected erythrocytes, investigated with a specific plasma membrane fluorescent probe.
    Deguercy A; Schrevel J; Duportail G; Laustriat G; Kuhry JG
    Biochem Int; 1986 Jan; 12(1):21-31. PubMed ID: 3511915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity of daunorubicin in trisomic (+21) human fibroblasts: relation to drug uptake and cell membrane fluidity.
    Przybylska M; Koceva-Chyla A; Rózga B; Józwiak Z
    Cell Biol Int; 2001; 25(2):157-70. PubMed ID: 11237420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measurement of fluidity of membrane lipids in lymphocytes from patients with pulmonary tuberculosis].
    Wang BN
    Zhonghua Jie He He Hu Xi Za Zhi; 1991 Apr; 14(2):67-8, 125. PubMed ID: 1879016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between flow cytometry and fluorometry for the kinetic measurement of membrane fluidity parameters.
    Collins JM; Grogan WM
    Cytometry; 1989 Jan; 10(1):44-9. PubMed ID: 2917474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescent probes DPH, TMA-DPH and C17-HC induce erythrocyte exovesiculation.
    Saldanha C; Santos NC; Martins-Silva J
    J Membr Biol; 2002 Nov; 190(1):75-82. PubMed ID: 12422273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of cancer multidrug resistance by green tea polyphenols.
    Mei Y; Qian F; Wei D; Liu J
    J Pharm Pharmacol; 2004 Oct; 56(10):1307-14. PubMed ID: 15482646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid fluidity of red cell membranes assessed with different fluorescent probes.
    Donner M; Stoltz JF
    Acta Med Port; 1985; 6(9-12):S27-30. PubMed ID: 3832811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.